CTLA4 and Miyoshi myopathy: However, immunotherapy with anti-PD-1 or anti-PD-L1 mAbs alone or in combination with anti-CTLA-4 mAbs showed promising activity in relapsing MM patients [3,4,5,6,7,8,9].